Menu
GeneBe

rs746478253

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5

The NM_015836.4(WARS2):​c.797del​(p.Pro266ArgfsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P266P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

WARS2
NM_015836.4 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:2

Conservation

PhyloP100: 9.30
Variant links:
Genes affected
WARS2 (HGNC:12730): (tryptophanyl tRNA synthetase 2, mitochondrial) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. This gene encodes the mitochondrial tryptophanyl-tRNA synthetase. Two alternative transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 6 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-119033196-CG-C is Pathogenic according to our data. Variant chr1-119033196-CG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 440918.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=4, Uncertain_significance=2}. Variant chr1-119033196-CG-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
WARS2NM_015836.4 linkuse as main transcriptc.797del p.Pro266ArgfsTer10 frameshift_variant 6/6 ENST00000235521.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
WARS2ENST00000235521.5 linkuse as main transcriptc.797del p.Pro266ArgfsTer10 frameshift_variant 6/61 NM_015836.4 P1Q9UGM6-1
WARS2ENST00000369426.9 linkuse as main transcriptc.*163del 3_prime_UTR_variant 6/61 Q9UGM6-2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152258
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000359
AC:
9
AN:
250918
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135680
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000795
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
36
AN:
1461872
Hom.:
0
Cov.:
31
AF XY:
0.0000289
AC XY:
21
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000315
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152258
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74398
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMay 05, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterApr 13, 2022- -
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 10, 2017- -
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxOct 21, 2022Frameshift variant predicted to result in protein truncation as the last 95 amino acids are replaced with 9 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 6447871, 17604309, 24639874, 28236339, 28905505, 28650581, 25385316, 25361775, 25130867, 27389904, 10828066, 15779907, 12557294, 2999114, 7219534, 6997870, 6932013, 31628766, 31617452, 31684799, 31282308, 29783990) -
Likely pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 29, 2018DNA sequence analysis of the WARS2 gene demonstrated a one base pair deletion in exon 6, c.797del. This deletion is predicted to result in a frameshift and creation of a premature stop codon nine amino acids downstream, p.Pro266Argfs*10. The c.797del has been described at a low population frequency of 0.004% in gnomAD. The second sequence change identified, c.938A>T, occurs in exon 6 and results in an amino acid change, p.Lys313Met. The p.Lys313Met change affects a moderately conserved amino acid residue located in a domain of the WARS2 protein that is known to be functional. This sequence change has been described in the gnomAD database with a low population frequency of 0.02% (dbSNP rs145867327). The c.797del and c.938A>T sequence changes have been reported in the trans state (on different chromosomes) in two affected siblings with WARS2-related phenotypes (Wortmann et al., 2017. Hum Mutat 38: 1786-1795). -
Parkinsonism-dystonia 3, childhood-onset Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMay 05, 2022- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 15, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746478253; hg19: chr1-119575819; API